Atlas Trials

SGI-110 in Combination With Carboplatin in Ovarian Cancer

Clinical trial NCT01696032 · COMPLETED

Trial details

NCT number
NCT01696032
Sponsor
Astex Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2012-09-01
Primary completion
2016-08-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.